Quest Diagnostics (DGX) Asset Writedowns and Impairment (2009 - 2019)

Quest Diagnostics has disclosed Asset Writedowns and Impairment across 11 years of filings, most recently posting $2.0 million for Q4 2019.

• In Q4 2019, Asset Writedowns and Impairment fell 50.0% year-over-year to $2.0 million; the TTM figure through Dec 2019 stood at $11.0 million (up 83.33% YoY), while the FY2024 annual figure was $5.0 million, up 400.0% from the prior year.
• Asset Writedowns and Impairment came in at $2.0 million for Q4 2019 at Quest Diagnostics, down from $4.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $86.0 million in Q1 2016 to a low of -$235.0 million in Q4 2016.
• Average Asset Writedowns and Impairment over 5 years is $16.4 million, with a median of $3.5 million recorded in 2017.
• Year-over-year, Asset Writedowns and Impairment plunged 461.54% in 2016 and jumped 133.33% in 2019.
• Over 5 years, Asset Writedowns and Impairment stood at $65.0 million in 2015, then sank by 461.54% to -$235.0 million in 2016, then jumped by 101.28% to $3.0 million in 2017, then surged by 33.33% to $4.0 million in 2018, then plunged by 50.0% to $2.0 million in 2019.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $2.0 million in Q4 2019, $4.0 million in Q3 2019, and $1.0 million in Q2 2019.